Metolazone Tablet
Product Images NDC 46708-532

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metolazone (NDC 46708-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Tablets (Metolazone 10)

Each tablet contains 10mg of Pettiozo, USP with NDC code 46708-534-31. This medication should not be substituted with formulations equivalent to Zaroxolyn and Metolazone and Mykrox as they may not have the same effect (see prescribing information). The tablets are manufactured by Alembic Pharmaceuticals Limited in their Formulation Division located in Village Panelav, P.O. Tapura, Near Basta, Taukarhab, Panchmahal 389350, Gujarat India.*

FDA Label Image

100 Tablets (Metolazone 2 5)

FDA Label Image

100 Tablets (Metolazone 5)

Each tablet contains 5mg of Melolazone, and it is not recommended to substitute it with other medications such as Mykrox®. This information is crucial, and the tablets are manufactured by Nlembic Pharmaceuticals Limited. The rest of the text contains information on where the tablets are made, their packaging, and other industry-specific details.*

FDA Label Image

Structure (Metolazone Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.